-
The studies, published in the journal Blood, suggest that the mRNA Covid-19 vaccine may have reduced efficacy in people with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer
-
According to the Ministry, cumulatively, 11,99,37,641 vaccine doses have been administered through 17,37,539 sessions, as per the provisional report till 7 a.m. on Saturday.
-
Centre’s policy to cover only those above 45 years faulted; people testing positive in 11-40 age group on the rise
-
The US Food and Drug Administration (FDA) and the Centres for Disease Control and Prevention (CDC) on Tuesday called for a pause on the Johnson & Johnson vaccine after six recipients of the jab developed a rare
-
Collector was speaking after launching the Covid vaccine Mahotsav at Outreach Centre in Polepally SEZ at Jedcherla on Monday
-
The health minister urged the Centre to give priority to Maharashtra, since the coronavirus cases were more in the state and the overall death toll was over 50,000.
-
Maharashtra, Gujarat, Rajasthan, Uttar Pradesh, West Bengal, Karnataka, Madhya Pradesh and Kerala account for 60 per cent of the cumulative vaccine doses given till now.
-
It's an appeal to all to take the vaccine...Do remember the mantra to fight corona- dawaayi bhi kadaayi bhi. It is not that I have to just say; we have to live too, speak too, tell too and keep making people committed
-
Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India. It has been tested against African and UK variants of COVID19 and has an overall efficacy of 89 per cent.
-
While addressing 'Reshape Tomorrow Summit' organised by The Economic Times on Friday, he also spoke about the vaccination drive currently underway, India's investment in the "Test, Track and Treat" strategy and Make in India vaccine.
-
"Unfortunately, I have tested positive for COVID-19. All those that have come in contact with me in the last 10 days are requested to please get themselves tested," Rawal wrote.
-
Vaccine hesitant people may have anxiety over safety concerns, or they might belong to a community that historically has mistrusted the medical establishment, according to the study.
-
TRS MPs also raised the issues of pending railway projects and medical colleges to the State.
-
The findings published in the journal Health Communication are based on evidence collected during the "swine flu," which was declared a pandemic by the World Health Organization in 2009.
-
The vaccine, NVX-CoV2373, was found 86.3 per cent effective against the B.1.1.7/501Y.V1 variant circulating in the UK, Novavax said on Thursday.
-
India's total active caseload stands at 1.76 lakh (1,76,319) which comprises 1.58 per cent of India's total infections.
-
The second phase of the nationwide Covid-19 vaccination drive for age-appropriate population groups began on Monday.
-
Public health officials have told Ministers in the UK that the remarkable results apply for both the Pfizer and Oxford-AstraZeneca vaccine, with the British jab proving slightly more effective, the report said.
-
"Although many people in rich countries will receive a vaccine for COVID-19 this year, many people in poor countries will likely have to wait years to get one".
-
The Covid-19 vaccines - Covaxin and Covishield, will be made available to the general public from today.